OliX Moves Into Spotlight Amid Strong RNAi Interest, New Platform

Big Pharma Deals To Follow?

 
• By Jung Won Shin
DNA_Spiral
OliX A Potential Dark Horse In RNAi Therapeutics? • Source: Shutterstock

More from South Korea

More from Focus On Asia